SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-018802
Filing Date
2022-07-07
Accepted
2022-07-07 16:15:26
Documents
13
Period of Report
2022-07-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42547
2 ex10-1.htm EX-10.1 42546
  Complete submission text file 0001493152-22-018802.txt   273853

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lctx-20220705.xsd EX-101.SCH 2968
4 XBRL LABEL FILE lctx-20220705_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE lctx-20220705_pre.xml EX-101.PRE 22795
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 221071810
SIC: 2836 Biological Products, (No Diagnostic Substances)